References
- Althoff, K. N., Buchacz, K., Hall, H. I., Zhang, J., Hanna, D. B., Rebeiro, P., … Brooks, J. T. (2012). U.S. Trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals of Internal Medicine, 157(5), 325–335. doi: 10.7326/0003-4819-157-5-201209040-00005
- Brooks, J. T., Buchacz, K., Gebo, K. A., & Mermin, J. (2012). HIV infection and older Americans: The public health perspective. American Journal of Public Health, 102(8), 1516–1526. doi: 10.2105/AJPH.2012.300844
- Centers for Disease Control and Prevention. (2007). HIV/AIDS surveillance report, 2005 (Vol. 17. Rev ed.). Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
- Centers for Disease Control and Prevention. (2011). HIV surveillance report, 2009 (Vol. 21). Retrieved August, 2016, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Published February 2011.
- Centers for Disease Control and Prevention. (2013a). HIV surveillance report, 2011 (Vol. 23). Retrieved August, 2016, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Published February 2013.
- Centers for Disease Control and Prevention. (2013b). Estimated percentages and characteristics of men who have sex with men and use injection drugs–United States, 1999–2011. The Morbidity and Mortality Weekly Report, 62(37), 757–762.
- Centers for Disease Control and Prevention. (2014). HIV surveillance supported by the division of HIV/AIDS prevention. Retrieved February 1, 2017, from https://www.cdc.gov/hiv/pdf/prevention_ongoing_surveillance_systems.pdf
- Centers for Disease Control and Prevention. (2015a). HIV surveillance report, 2014 (Vol. 26). Retrieved August, 2016, from http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2015.
- Centers for Disease Control and Prevention. (2015b). HIV surveillance report, 2013 (Vol. 25). Retrieved August, 2016, from http://www.cdc.gov/hiv/library/reports/surveillance/. Published February 2015.
- Centers for Disease Control and Prevention. (2016). NCHHSTP Atlas. Retrieved from http://www.cdc.gov/nchhstp/atlas/.
- Hall, H. I., Green, T. A., Wolitski, R. J., Holtgrave, D. R., Rhodes, P., Lehman, J. S., … Mermin, J. H. (2010). Estimated future HIV prevalence, incidence, and potential infections averted in the United States: A multiple scenario analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(2), 271–276. doi: 10.1097/QAI.0b013e3181e8f90c
- Harrison, K. M., Kajese, T., Hall, H. I., & Song, R. (2008). Risk factor redistribution of the national HIV/AIDS surveillance data: An alternative approach. Public Health Reports, 123(5), 618–627. doi: 10.1177/003335490812300512
- Institute of Medicine. (2012). Monitoring HIV care in the United States: Indicators and data systems. Washington, DC: The National Academies Press.
- Johnson, A. S., Hall, H. I., Hu, X., Lansky, A., Holtgrave, D. R., & Mermin, J. (2014). Trends in diagnoses of HIV infection in the United States, 2002–2011. The Journal of the American Medical Association, 312(4), 432–434. doi: 10.1001/jama.2014.8534
- Justice, A. C. (2012, September). Overview of ageing: How can we optimize care in the context of multimorbidity?. Royal Society of Medicine (RSM), Justice, AC.
- Lansky, A., Finalyson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., … Crepaz, N. (2012). Estimating the number of injection drug users in the United States to calculate national rates of HIV Infection. Paper presented at the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention, and Access to Care, Washington, DC.
- Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., … Crepaz, N. (2014). Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One, 9(5), e97596. doi: 10.1371/journal.pone.0097596
- Lansky, A., Johnson, C., Oraka, E., Sionean, C., Joyce, M. P., DiNenno, E., & Crepaz, N. (2015). Estimating the number of heterosexual persons in the United States to calculate national rates of HIV infection. PLoS One, 10(7), e0133543. doi: 10.1371/journal.pone.0133543
- Purcell, D. W., Johnson, C. H., Lansky, A., Prejean, J., Stein, R., Denning, P., … Crepaz, N. (2012). Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. The Open AIDS Journal, 6, 98–107. doi: 10.2174/1874613601206010098
- Shah, M., Perry, A., Risher, K., Kapoor, S., Grey, J., Sharma, A., … Dowdy, D. W. (2016). Effect of the US National HIV/AIDS strategy targets for improved HIV care engagement: A modelling study. The Lancet HIV, 3(3), e140–e146. doi: 10.1016/S2352-3018(16)00007-2
- Tempalski, B., Pouget, E. R., Cleland, C. M., Brady, J. E., Cooper, H. L., Hall, H. I., … Friedman, S. R. (2013). Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992–2007. PLoS One, 8(6), e64789. doi: 10.1371/journal.pone.0064789
- United States Census Bureau. (2012). Projected population by single year of age, sex, race, and hispanic origin for the United States: 2012 to 2060. Retrieved from https://www.census.gov/population/projections/data/national/2012.html
- Xia, Q., Braunstein, S. L., Wiewel, E. W., Eavey, J. J., Shepard, C. W., & Torian, L. V. (2016). Persons living with HIV in the United States: fewer than we thought. The Journal of Acquired Immune Deficiency Syndromes, 72(5), 552–557.